Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• Phase Ib: to define the maximum tolerated dose (MTD)/ recommended Phase II of E7080 administered in combination with carboplatin + gemcitabine in patients with platinum-sensitive recurrent ovarian cancer. • Phase II: to evaluate the safety and tolerability of E7080 administered in combination with carboplatin + gemcitabine, compared with carboplatin + gemcitabine alone, in patients with platinum-sensitive recurrent ovarian cancer.
Critère d'inclusion
- Platinum sensitive recurrent ovarian cancer